Last updated: April 17, 2024
Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine
Overall Status: Active - Recruiting
Phase
N/A
Condition
Gall Bladder Disorders
Treatment
IDUS examination
Clinical Study ID
NCT06265311
20221307-2
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 1.Clinical diagnosis of common bile duct stones 2.At least one of the following,diameter of CBD>1.5cm, or number of calculi>2, or lithotripsy during ercp
Exclusion
Exclusion Criteria:
- Clinical diagnosis of liver or biliary malignant tumor. 2. Clinical diagnosis ofduodenal malignant tumor 3. Failure or unexpected termination of ERCP 4. Surgeryhistory of gallbladder or bile duct.
Study Design
Total Participants: 80
Treatment Group(s): 1
Primary Treatment: IDUS examination
Phase:
Study Start date:
November 02, 2021
Estimated Completion Date:
June 30, 2024
Study Description
Connect with a study center
Shang General Hospital
Shanghai, 200080
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.